Background: Lateral hypothalamus (LH) involves in modulation of tonic pain. Regarding the direct and indirect neural connections between the LH and nucleus accumbens (NAc), we aimed to examine the pain modulatory role of NAc dopamine receptors in modulation of LH-induced analgesia in the formalin test. Methods: Vehicle-control groups received saline or DMSO into the NAc and saline into the LH. Carbachol-control groups received carbachol (250 nmol/L) into the LH, 5 min after saline or DMSO injection into the NAc. In treatment groups, intra-NAc administration of SCH-23390 or sulpiride (D1-and D2-like dopamine receptor antagonists, respectively) was performed 5 min before carbachol injection. Formalin test was done in all rats 5 min after the second injection. Results: The blockade of NAc dopamine receptors reduced carbacholinduced antinociception during both phases of formalin test and reduction in LH-induced analgesia during the late phase was more than that during the early phase. Furthermore, contribution of D2-like dopamine receptors to mediation of anti-hyperalgesic effect of carbachol was greater than that of D1-like dopamine receptors during the late phase. Conclusions: The findings suggest that LH-VTA-NAc circuit is contributed to the modulation of formalin-induced pain. These findings demonstrate that transmission at D1-and D2-like dopamine receptors mediates the LH-induced analgesia. Significance: Blockade of accumbal dopamine receptors attenuated analgesia induced by carbachol injection into the lateral hypothalamus during both phases of formalin test. Effect of blockade of D1-and D2-like dopamine receptors on reduction in antinociception was more during the late phase. Contribution of D2-like dopamine receptors to mediation of antinociception during the late phase was greater than the early phase.
Introduction
In a pioneering study conducted by Franklin (1989) , it was supposed that analgesia and reward might be two processes related to each other because analgesics like morphine have the potential of abuse. Accordingly, there might be some overlaps between the neural substrates involved in processing of analgesia and reward (Franklin, 1989) . Ventral tegmental area (VTA) and nucleus accumbens (NAc) are sites entangled in motivation and reward processing (Wolf, 2002) . The role of descending spinal inhibitory pathways that originate from the brain system and terminate in dorsal horn of spinal cord has been demonstrated in control of pain (Millan, 2002; Ossipov et al., 2010) . However, the role of brain substrates located rostral to the brain stem, like the VTA and NAc, in control of pain was neglected for years. In 1990, Morgan and Franklin demonstrated that VTA dopamine depletion by 6-hydroxydopamine (6-OHDA) reduces analgesia induced by systemic administration of morphine and D-amphetamine in the formalin test as a model of tonic pain. Later, Altier and Stewart (1999) showed that intra-VTA injection of morphine and substance P (SP) analogue, DiMe-C7, NK-1 and NK-3 receptor agonists or amphetamine reduces nociceptive responses in the formalin test. In addition, they supposed that antinociceptive effect of VTA is mediated through the NAc. In this respect, the administration of dopamine receptor antagonists into the NAc led to reduction in analgesia induced by intra-VTA injection of morphine or SP. These findings demonstrate that VTA dopaminergic neurons have a role in modulation of tonic pain (Altier and Stewart, 1999) .
Electrical stimulation of the lateral hypothalamus (LH) induces analgesia in the formalin test (Lopez et al., 1991) . In addition, carbachol, a cholinergic receptor agonist, increases the firing rate of LH neurons including SP and orexin neurons and attenuates nociceptive responses in the acute and formalininduced pain models (Holden and Pizzi, 2008; Ohno et al., 2008; Moradi et al., 2015a,b; Ezzatpanah et al., 2015 Ezzatpanah et al., , 2016 . Neuroanatomical evidences have shown that LH has neuronal connections with dopamine neurons in the VTA and NAc neurons (Peyron et al., 1998) . Furthermore, the VTA dopamine neurons send their projections to the cortical and limbic forebrain regions like the NAc (Fadel and Deutch, 2002) . In our recent studies, we showed that D1-and D2-like dopamine receptors into the VTA and NAc are involved in modulation of LH-induced analgesia in the tail-flick test -as a model of acute pain (Moradi et al., 2015a,b) . In this respect, it was demonstrated that intra-VTA or -NAc administration of D1-and D2-like dopamine receptor antagonists reduced antinociception induced by intra-LH injection of carbachol.
In this study, we studied the role of dopaminergic receptors in the NAc in modulation analgesia induced by intra-LH injection of carbachol in the formalin test. In this respect, D1-or D2-like dopamine receptor antagonists were injected into the NAc before carbachol injection in the LH. The aim of this study was to shed light on the involvement of supraspinal sites in modulation of tonic pain.
Methods

Subjects
Seventy-nine adult male albino Wistar rats (Pasteur Institute, Tehran, Iran) weighing between 220 and 250 g were used in this study. Rats were provided by free access to food and water during the whole period of experiments. They were kept in a 12/12 h light/dark cycle (lights off at 7 p.m.).
Drugs
A 250 nmol/L carbachol solution [Carbamylcholine chloride (a cholinergic receptor agonist); SigmaAldrich, St. Louis, MO, USA], 0.25, 1 and 4 nmol/L solutions of SCH-23390 (a selective D1-like dopamine receptor antagonist; Tocris Bioscience, Bristol, UK) and 0.25, 1 and 4 nmol/L solutions of sulpiride (a selective D2-like dopamine receptor antagonist; Tocris Bioscience) were used in this study. The carbachol and SCH-23390 are soluble in saline and sulpiride is soluble in DMSO 12%. The volume of injections into the LH and NAc was 0.5 lL. Fifty microlitre Formalin 2.5% [prepared by diluting 37% formaldehyde (Merck, Germany) with normal saline] was also used for induction of nociception.
Experiments
Experiments were carried out in accordance with the Guide for the Care and Use of Laboratory Animals (National Institutes of Health Publication No. 80-23, revised 1996) and were confirmed by the Research and Ethics Committee of Shahid Beheshti University of Medical Sciences, Tehran, Iran.
One week before initiating the experiments, rats were anesthetized by intraperitoneal injection of a mixture of xylazine 2% (10 mg/kg) and ketamine 10% (100 mg/kg). According to the rat brain atlas (Paxinos and Watson, 2007) , the coordinates for the perifornical part of the LH and NAc were: for the LH: AP = 2.65 AE 0.15 mm caudal to the bregma, Lat = AE1.3 mm lateral to the midline and DV = 8.6 mm ventral from the skull surface; and for the NAc: AP = 1.6 AE 0.15 mm rostral to the bregma, Lat = AE1.6 mm lateral to the midline and DV = 7.8 mm ventral from the skull surface. Two 23-gauge stainless steel guide cannulae were inserted unilaterally into the skull 1 mm above the LH and NAc.
2.3.1 Effects of intra-NAc administration of SCH-23390 on the antinociception induced by intra-LH microinjection of carbachol According to our previous study, 250 nmol/L solution of carbachol reduced formalin-induced pain effectively (Ezzatpanah et al., 2015) . Therefore, in this study 250 nmol/L solution of carbachol was used as an effective dose.
To examine the role of NAc D1-like dopamine receptors in modulation of LH-induced analgesia, experimental groups were microinjected with 0.5 lL SCH-23390 (0.25, 1 and 4 nmol/L) into the NAc, 5 min prior to the microinjection of 0.5 lL carbachol (250 nmol/L) into the LH. Carbachol-control group received 0.5 lL saline as a drug vehicle into the NAc, 5 min before intra-LH administration of 0.5 lL carbachol. Animals in the vehicle-control group were microinjected with 0.5 lL saline into the NAc and LH. All rats were injected subcutaneously with 50 lL of formalin 2.5% into the plantar surface of the hind paw, 5 min after intra-LH microinjection of carbachol or saline (5-7 in each group).
Effects of intra-NAc administration of sulpiride on the antinociception induced by intra-LH microinjection of carbachol
In the second part of the study, to study the role of NAc D2-like dopamine receptors in modulation of LH-induced analgesia, experimental groups were microinjected with 0.5 lL sulpiride (0.25, 1 and 4 nmol/L) into the NAc, 5 min prior to the microinjection of 0.5 lL carbachol (250 nmol/L) into the LH. Carbachol-control group received 0.5 lL DMSO 12% as drug vehicle into the NAc, 5 min before intra-LH administration of 0.5 lL carbachol. Animals in the vehicle-control group were microinjected with 0.5 lL DMSO 12% and saline into the NAc and LH, respectively. 5 min after intra-LH microinjection of carbachol or saline, rats were injected subcutaneously with formalin 2.5% into the plantar surface of the hind paw (6-7 in each group).
The effect of carbachol injection alone into some brain regions surrounding the LH (n = 4) or the effect of carbachol administration into the LH in combination with the injection of 4 nmol/L solution of D1-or D2-like dopamine receptor antagonists into some brain regions next to the NAc (n = 5 in each group) were also examined. This was done to distinguish between the results specific to drug injections into the LH and NAc, and those obtained from drug injections into the surrounding regions.
Drug administration
On the day of test, two microinjections were done before the formalin test. A stainless steel injector (30 gauge needle; 1 mm longer than guide cannulae) was used for injecting the drug into the LH and NAc. The injector was connected to a polyethylene tube . A 1-lL Hamilton syringe was used for injection of drug through the microtube. Intra-NAc microinjection of dopamine receptor antagonists or drug vehicles (DMSO 12% or saline) was done 5 min prior to microinjection of carbachol or saline into the LH. Formalin test was carried out 5 min after the second microinjection.
Formalin test
Dubuisson and Dennis invented formalin test in 1977. This test is widely used as a model of persistent (tonic) pain. In all experiments, 5 min after the microinjection of the carbachol or saline, 50 lL of 2.5% formalin was injected subcutaneously into the plantar surface of the hind paw contralateral to the surgery side. Rats were immediately placed in the transparent open Plexiglas chamber (35 9 35 9 35 cm 3 ) with a mirror angled at 45°used for observing the animal's behaviour during the formalin test. Nociceptive behaviours were quantified as follows: 0, the position and posture of the injected hind paw was indistinguishable from the another hind paw; 1, reduction in the weight put on the paw which was injected with formalin; 2, the injected paw was elevated and was not in contact with any surface; 3, the injected paw was licked, shaken or bitten. Time spent in each type of behaviour was recorded in 5-min blocks for 60-min test period (Ezzatpanah et al., 2015) . Then, a weighted nociceptive score with a range of 0-3 was calculated for each 5-min block of time:
Histological verification of samples and data analysing were done after the formalin test.
Histology
After collecting the data and completion of the test, animals were deeply anesthetized with ketamine and xylazine and sacrificed. Their brains were removed and 50-lm transverse brain sections were provided. The cannulae tracts were traced and compared with drawings of the LH and NAc position in the rat brain atlas (Paxinos and Watson, 2007) . Only the animals with correct cannulae placements were included in the data analysis. Cannulae placements are shown in schematic drawing in Fig. 1 .
Data analysis
All statistical analyses were performed using Graph Pad Prism 6 (Graph Pad Prism, San Diego, California, USA). The obtained results were expressed as mean AE SEM (standard error of mean). The differences with p-values less than 0.05 were considered statistically significant. The mean nociceptive scores of different groups (vehicle-control, carbachol-control and experimental groups) were compared by two-way ANOVA followed by Bonferroni's test to show the effects of treatment and time on nociceptive scores. To evaluate the nociceptive responses during the early or late phases, AUC values (area under the curve) were calculated as raw nociceptive scores 9 time by linear trapezoidal method and a single value (AUC) was subjected to one-way ANOVA followed by Newman-Keuls test. One-way ANOVA followed by Dunnett's test was used to calculate the percentage decrease in the AUC values, which were calculated for nociceptive scores of the carbachol-control and experimental groups compared to the AUC values of vehicle-control group during the early and late phases. Finally, two-way ANOVA followed by Bonferroni's test was used to determine the effects of time (early or late phase of formalin-induced pain) and treatment on the AUCs of treatment groups compared to those of carbacholcontrol group.
Results
3.1 Effects of intra-NAc administration of SCH-23390 on the antinociception induced by intra-LH microinjection of carbachol Two-way ANOVA followed by Bonferroni's post-hoc test was used to study the effects of time and treatment on the nociceptive scores [Treatment effect: F (42,75) = 60.57, p < 0.0001; Time effect: F (11,275) = 7.941, p < 0.0001; Treatment and time interaction effect: F (44,275) = 1.195, p = 0.1984]. The results showed that carbachol injection into the LH significantly attenuated nociceptive scores compared to the vehicle-control group and pretreatment of the NAc with SCH-23390 (0.25, 1 and 4 nmol/L) reduced the antinociceptive effect of carbachol (Fig. 2) .
One-way ANOVA followed by Newman-Keuls test was used to compare the AUC values during the early [F (4,30) = 24.38, p < 0.0001; Fig. 3A ] and late [F (4,30) = 37.99, p < 0.0001; Fig. 3B ] phases. The results showed that carbachol administration reduces the AUC values in comparison with the vehicle-control group (p < 0.001) and intra-NAc injection of SCH-23390 alleviates LH-induced antinociception during both phases, which is represented as an increase in the AUC values. During the early and late phases, 0.25 nmol/L solution of SCH-23390 increased the nociceptive responses but this difference was not significant in comparison with carbachol-control group. In contrast, 4 nmol/L solution of SCH-23390 significantly diminished antinociceptive effects of carbachol during both phases (p < 0.001). Intra-NAc injection of 1 nmol/L solution of SCH-23390 significantly attenuated carbachol-induced antinociception during the late phase (p < 0.05), but not during the early phase (Fig. 3) .
Changes in AUC values of carbachol-control and SCH-23390 treated groups compared to the AUC values of vehicle-control group
The AUC values were normalized and AUC values of treatment groups were compared to the AUC values of carbachol-control group (Fig. 4) . One-way ANOVA followed by Dunnett's test showed significant differences between the treatment groups and carbachol-control group during the early [F (4,30) = 26.3, p < 0.0001; The AUC values of experimental groups were compared to those of carbachol-control group. The AUC values in animals which had received 0.25 nmol/L solution of SCH-23390 showed the highest similarity to those of carbachol-control group during both phases. On the other hand, administration of 4 nmol/L solution of SCH-23390 showed the lowest similarity to AUC values of carbachol-control group during the early and late phases. Compared to the AUC values of carbachol-control group, AUC values of experimental groups (0.25, 1 and 4 nmol/L solutions of SCH-23390) were less during the late phase compared to the early phase. Furthermore, the magnitude of 50% effective dose (ED50) of SCH-23390 during the early phase (2.23 nmol/L) was greater than the late phase (1.04 nmol/L). Altogether, these data demonstrate that contribution of D1-like dopamine receptors to mediation of LH-induced analgesia and anti-analgesic effect of SCH-23390 during the late phase is considerably more than the early phase.
Effects of intra-NAc administration of sulpiride on the antinociception induced by intra-LH microinjection of carbachol
In the second part of study, two-way ANOVA followed by Bonferroni's post-hoc test was used to study the effects of time and treatment on the nociceptive scores [Treatment effect: F (4,319) = 30.91, p < 0.0001; Time effect: F (11,319) = 6.664, p < 0.0001; Treatment and time interaction effect: F (44,319) = 1.121, p = 0.2862]. Here, pretreatment of the NAc with sulpiride (0.25, 1 and 4 nmol/L) attenuated the analgesic effect of carbachol in the formalin test (Fig. 6) .
To compare the AUC values during the early [F (4,33) = 29.09, p < 0.0001; Fig. 7A ] and late [F (4,33) = 22.16, p < 0.0001; Fig. 7B ] phases, oneway ANOVA followed by Newman-Keuls test was done. The results showed that AUC values were reduced by carbachol administration into the LH; and intra-NAc injection of sulpiride alleviated LHinduced antinociception that is represented as an increase in AUC values during both phases. During the early and late phases, 0.25 nmol/L solution of sulpiride increased the nociceptive responses but this difference was not significant in comparison with carbachol-control group. A total of 1 and 4 nmol/L solutions of sulpiride significantly diminished antinociceptive effects of carbachol during both phases (p < 0.01 and p < 0.001, respectively).
Changes in AUC values of carbachol-control and sulpiride treated groups compared to the AUC values of vehicle-control group
The AUC values were normalized and AUC values of treatment groups were compared to the AUC values of carbachol-control group (Fig. 8) . One-way ANOVA followed by Dunnett's test showed significant differences between the treatment groups and carbachol-control group during the early [F (4,33) = 38.06, p < 0.0001; Fig. 8 left] and late [F (4,33) = 26.13, p < 0.0001; Fig. 8 right] phases.
Similar to the previous set of experiments, changes in the AUC values of carbachol-control group compared to the AUC values of the vehicle-control group were set as 100% (Fig. 9) . The AUC values of the experimental groups were compared to those of carbachol-control group. As it can be seen in Fig. 9 , the AUC values in the experimental groups that had received 0.25 and 4 solutions of sulpiride showed the highest and lowest similarity to those of carbachol-control group, respectively. Compared to the AUC values of carbachol-control group, AUC values in the groups which had received 0.25 and 1 nmol/L solutions of sulpiride, were less during the late phase compared to the early phase. The magnitude of 50% effective dose (ED50) of the intra-NAc administration of sulpiride during the early phase (1.45 nmol/ L) was more than that of the late phase (0.654 nmol/L); demonstrating that contribution of D2-like dopamine receptors to modulation of LH-induced analgesia and anti-analgesic effect of sulpiride during the late phase is considerably more than those during the early phase. Carbachol injection into some areas close to the LH did not have any antinociceptive effect. In addition, administration of 4 nmol/L solutions of SCH-23390 or sulpiride into the some areas close to the NAc before intra-LH administration of carbachol was similar to those of carbachol-control group, that is, they did not reduce the LH-induced antinociception.
Discussion
In summary, the results of present study showed that blockade of accumbal D1-and D2-like dopamine receptors using SCH-23390 and sulpiride reduced LH-induced antinociception, and reduction in LH-induced analgesia during the late phase was more than that during the early phase. Furthermore, contribution of D2-like dopamine receptors on mediation of anti-hyperalgesic effect of carbachol was greater than that of D1-like dopamine receptors during the late phase.
Previous studies have revealed that intra-LH injection of carbachol, a cholinergic receptor agonist, reduced nociceptive responses in the phasic, tonic and neuropathic pain models (Holden et al., 2014; Moradi et al., 2015a,b; Ezzatpanah et al., 2016) . Carbachol increases the firing rate of orexin neurons (Ohno et al., 2008) . Immunohistochemistry studies have shown that orexin neurons send their projections to different neuronal substrates including the VTA and NAc (Peyron et al., 1998) . Orexin receptors are found in the VTA and NAc (Marcus et al., 2001; Narita et al., 2006) . In this respect, in vitro electrophysiological (Korotkova et al., 2003) and in vivo (Muschamp et al., 2007) studies have proved that orexins increase the firing rate of VTA dopaminergic and GABAergic neurons. In our previous study, it was shown that intra-VTA administration of orexin-1 and -2 receptor antagonists before carbachol administration into the LH reduced LHinduced analgesia (Ezzatpanah et al., 2016) . In that study, we suggested that the antinociception evoked by activation of VTA orexin receptors might be partially due to the activation of VTA dopamine neurons, which mainly project to the NAc. Here, the obtained results suggest that the release of orexin into the VTA may give rise to the activation of VTA dopamine neurons and dopamine release into the NAc; because the administration of D1-and D2-like dopamine receptor antagonists into the NAc attenuated LH-induced analgesia during both phases of formalin test. We suppose that the contribution of NAc dopaminergic receptors in modulation of LHinduced analgesia may be related to orexin transmission in the VTA. These findings are in line with previous studies, which showed that intra-NAc administration of dopamine receptor antagonists reduced LH-induced analgesia in the tail-flick test (Moradi et al., 2015a,b) . This demonstrates that NAc is a common substrate for modulation of phasic and tonic pain.
Mesolimbic dopaminergic neurons located in the VTA primarily project to the sites that have main roles in motivation and reward processing including the prefrontal cortex and NAc (Wolf, 2002) . In this context, in one study carbachol injection into the LH induced condition place preference (CPP) and pretreatment of NAc with SCH-23390 or sulpiride reduced carbachol-induced CPP (Haghparast et al., 2013) . Aversion and reward are considered as two phenomena located at the opposite ends of a behavioural continuum (Spinoza, 1985) . Franklin (1989) assumed that pain and analgesia are aversive and rewarding stimuli, respectively. Therefore, the reduction in LH-induced analgesia after the administration of D1-and D2-dopamine receptor antagonists suggest that antinociception evoked by LH stimulation may be due to rewarding effect of activated dopaminergic system and its effect on changing mood to a positive status that is called dissociative analgesia and primarily is not related to reduction in sensory input (Franklin, 1989) . The reduction in LH-induced analgesia after blockade of dopamine receptors was more during the second phase of formalin-induced pain. In this respect, involvement of D1-like dopamine receptors in modulation of LH-induced antinociception was more during the late phase because intra-NAc injection of 1 nmol/L solution of SCH-23390 significantly attenuated carbachol-induced antinociception during the late phase (p < 0.05) but not during the early phase. These results are in line with previous findings, which show that contribution of neural substrate rostral to the brain stem, like VTA and NAc, in modulation of tonic pain is more than phasic pain (Altier and Stewart, 1999) .
While the activation of D1-like dopamine receptors, including D1 and D5 dopamine receptors, through recruitment of Gq proteins increases the activity of neurons, the D2-like receptors, including D2, D3 and D4 receptors, act through Gi/o proteins and attenuates the neuronal activity (Missale et al., 1998; Vallone et al., 2000) . However, although intra-cellular signalling mechanisms of D1-and D2-like dopamine receptors are different from each other, the effect of blockade of both NAc D1-and D2-like dopamine receptors were almost similar; that is, reduction in LH-induced analgesia. Different localization of dopamine receptors in the NAc may be helpful in interpretation of obtained results. The NAc dopamine receptors are found as postsynaptic D1-and D2-like dopamine receptors and presynaptic D2-like dopamine autoreceptors, which the later are expressed on dopamine neurons and regulates the release of dopamine (Wood, 2006) .
The next finding of present study was that the sulpiride reduced LH-induced analgesia more than SCH-23390. This supposes that the contribution of D2-like dopamine receptors in mediation of antinociceptive effect of LH is higher than D1-like dopamine receptors. This finding is consistent with the study conducted by Taylor et al. (2003) who demonstrated that intra-NAc microinjection of selective D2-like dopamine receptor agonist quinpirole blocked tonic pain in a dose dependent manner; while the injection of D1-like dopamine receptor into the NAc induced no analgesia. However, more studies are needed to shed light on the mechanisms underlying the contribution of D1 and D2-like dopamine receptors in mediation of LH-induced analgesia.
Carbachol injection into the LH induces release of orexins into the NAc. In this respect, intra-NAc administration of orexin-2 receptor antagonist attenuated LH-induced analgesia (Yazdi et al., 2016) . Therefore, it seems that the interaction between the orexinergic and dopaminergic receptors in the NAc play a determining role in modulation of antinociception induced by carbachol injection into the LH. The activation of LH SP neurons by carbachol (Holden and Pizzi, 2008) and mediation of LH-induced analgesia through recruitment of orexin receptors located in the loci related to pain modulation is also possible. These suggestions need more investigations.
Finally, the results showed that the antinociception is due to the effect of carbachol on the LH neurons because carbachol injection into some areas close to the LH did not have any antinociceptive effect. In addition, administration of 4 nmol/L solutions of SCH-23390 or sulpiride into the some areas close to the NAc before intra-LH administration of carbachol was similar to those of carbachol-control group. Accordingly, it can be assumed that observed results are most likely due to the effect of drug administration into the LH and NAc not neighbouring areas.
In conclusion, it was demonstrated that orexin transmission in the VTA and dopamine release into the NAc involves in modulation of LH-induced analgesia. Pain modulatory role of NAc dopamine receptors in the formalin test reveals that LH-VTA-NAc circuitry has a role not only in reward processing but also in pain modulation.
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